文献
J-GLOBAL ID:201802280597555999
整理番号:18A0260124
慢性閉塞性肺疾患(Trinity)のための単一吸入器超微粒子3剤併用療法と長時間作用性ムスカリン拮抗薬治療:二重盲検,並行群間,無作為化対照試験【Powered by NICT】
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
著者 (14件):
Vestbo Jorgen
(Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK)
,
Vestbo Jorgen
(University Hospital South Manchester NHS Foundation Trust, Manchester, UK)
,
Vestbo Jorgen
(Medicines Evaluation Unit, Manchester, UK)
,
Papi Alberto
(Research Centre on Asthma and COPD, University of Ferrara, Ferrara, Italy)
,
Corradi Massimo
(Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy)
,
Blazhko Viktor
(Pulmonology Department No 2, Kharkiv City Clinical Hospital No 13, Kharkiv, Ukraine)
,
Montagna Isabella
(Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy)
,
Francisco Catherine
(Global Clinical Development, Chiesi SAS, Courbevoie, France)
,
Cohuet Geraldine
(Global Clinical Development, Chiesi SAS, Courbevoie, France)
,
Vezzoli Stefano
(Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy)
,
Scuri Mario
(Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy)
,
Singh Dave
(Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK)
,
Singh Dave
(University Hospital South Manchester NHS Foundation Trust, Manchester, UK)
,
Singh Dave
(Medicines Evaluation Unit, Manchester, UK)
資料名:
Lancet
(Lancet)
巻:
389
号:
10082
ページ:
1919-1929
発行年:
2017年
JST資料番号:
B0673A
ISSN:
0140-6736
CODEN:
LANCA
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)